Shandong Teamgene Technology Co. Ltd. A Total Liabilities
Shandong Teamgene Technology Co. Ltd. A total liabilities. Based on the latest financial reports, Shandong Teamgene Technology Co. Ltd. A (603151) has total liabilities worth CN¥2.46 Billion CNY (≈ $360.02 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 603151 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shandong Teamgene Technology Co. Ltd. A (2020–2025)
Total liabilities of Shandong Teamgene Technology Co. Ltd. A from 2020 to 2025. This chart illustrates how Shandong Teamgene Technology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data.
Shandong Teamgene Technology Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Shandong Teamgene Technology Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sunny Loan Top Co Ltd
SHG:600830
|
China | CN¥3.98 Billion |
|
Genbyte Technology Inc
SHE:003028
|
China | CN¥981.62 Million |
|
Zhangjiagang Freetrade Science and Technology Co Ltd
SHG:600794
|
China | CN¥444.04 Million |
|
Meorient
SHE:300795
|
China | CN¥240.36 Million |
|
C.E. Info Systems Limited
NSE:MAPMYINDIA
|
India | Rs-9.05 Billion |
|
Audax Renovables S.A.
MC:ADX
|
Spain | €1.16 Billion |
|
AS Merko Ehitus
F:MKS
|
Germany | €160.49 Million |
|
Empresa Distribuidora y Comercializadora Norte SA ADR
NYSE:EDN
|
USA | $3.61 Trillion |
Liability Composition Analysis (2020–2025)
This chart breaks down Shandong Teamgene Technology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Shandong Teamgene Technology Co. Ltd. A balance sheet assets.
Liquidity & Leverage Metrics
Shandong Teamgene Technology Co. Ltd. A Total Liabilities Ratios Explained
Shandong Teamgene Technology Co. Ltd. A total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.83 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Teamgene Technology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Teamgene Technology Co. Ltd. A (2020–2025)
The table below shows the annual total liabilities of Shandong Teamgene Technology Co. Ltd. A from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.92 Billion ≈ $281.27 Million |
+270.67% |
| 2024-12-31 | CN¥518.56 Million ≈ $75.88 Million |
+121.82% |
| 2023-12-31 | CN¥233.77 Million ≈ $34.21 Million |
+43.20% |
| 2022-12-31 | CN¥163.25 Million ≈ $23.89 Million |
+33.45% |
| 2021-12-31 | CN¥122.33 Million ≈ $17.90 Million |
-24.43% |
| 2020-12-31 | CN¥161.87 Million ≈ $23.69 Million |
-- |
About Shandong Teamgene Technology Co. Ltd. A
Shandong Teamgene Technology Co., Ltd. engages in the research, development, production, and sale of pig feed that focuses on animal life and animal nutrition research in China. It offers pig feed, egg and poultry premixes, meat ruminant feed, and aquatic products; livestock breeding, as well as sales veterinary drug. The company was founded in 2007 and is based in Zibo, China.